Pathway | P-value | q-value |
---|---|---|
Experiment Ia | Â | Â |
   p53 signaling pathway, CCND1 and PCNA | 0.0064 | 0.0362 |
   small Leucine-rich Proteoglycan(SLRP) molecules, Lum | 0.0468 | 0.1131 |
   SREBP control of lipid synthesis | 0.0236 | 0.0319 |
Experiment II b | Â | Â |
   extrinsic prothrombin activation pathway, F5, F7, Fgb and Fga | 0.001 | 0.004 |
   intrinsic prothrombin activation pathway, F5, F9, Fgb and Fga | 0.0015 | 0.0151 |
   fibrinolysis pathway, serpine 1, Fgb and Fga | 0.0016 | 0.0152 |
   complement pathway | 0.0017 | 0.018 |
   inactivation of Gsk3 by AKT causes accumulation of b-catenin in alveolar macrophages | 0.0024 | 0.0170 |
   platelet amyloid precursor protein pathway, F9 and Serpine 1 | 0.0392 | 0.1788 |
   α-synuclein and Parkin-medicated proteolysis in Parkinson disease, Snca | 0.0455 | 0.1788 |
Experiment III c | Â | Â |
   alternative complement pathway | 0.0127 | 0.0644 |
   lectin induced complement pathway | 0.0158 | 0.0209 |
   classical complement pathway | 0.0174 | 0.0209 |
   fibronolysis pathway | 0.0174 | 0.0209 |
   extrinsic prothrombin activation pathway | 0.0205 | 0.0209 |
   complement pathway | 0.0252 | 0.0214 |